Carlo Toniatti

Role of IL-6 and Its Soluble Receptor in Induction of Chemokines and Leukocyte Recruitment

Maria Romano, Marina Sironi, Carlo Toniatti et al. · Immunity · 1997 · 1.1K citations · Full text

Inflammation, Cytokine, Chemokine Biology +10

An inhibitor of oxidative phosphorylation exploits cancer vulnerability

Jennifer R. Molina, Yuting Sun, Marina Protopopova et al. · Nature Medicine · 2018 · 903 citations · Full text

Medicine, Anti-cancer Agent, Cancer Vulnerability +4

Co-occurring Genomic Alterations Define Major Subsets of <i>KRAS</i> -Mutant Lung Adenocarcinoma with Distinct Biology, Immune Profiles, and Therapeutic Vulnerabilities

Ferdinandos Skoulidis, Lauren A. Byers, Lixia Diao et al. · Cancer Discovery · 2015 · 883 citations · Full text

The poly(ADP-ribose) polymerase inhibitor niraparib (MK4827) in BRCA mutation carriers and patients with sporadic cancer: a phase 1 dose-escalation trial

Shahneen Sandhu, William R. Schelman, George Wilding et al. · The Lancet Oncology · 2013 · 551 citations

Sporadic Cancer, Medicine, Brca Mutation Carriers +7

Interleukin (IL)-6 gene expression in the central nervous system is necessary for fever response to lipopolysaccharide or IL-1 beta: a study on IL-6-deficient mice.

Zhen Chai, S. Gatti, Carlo Toniatti et al. · The Journal of Experimental Medicine · 1996 · 345 citations · Full text

Central Il-6, Immune Regulation, Immunology +19